All In MedTech

Device Trial Radar · NCT05785832

A Randomized Trial Evaluating Control-IQ+ Technology in Adults With Type 2 Diabetes

A Randomized Trial Evaluating the Efficacy and Safety of Control-IQ+ Technology in Adults With Type 2 Diabetes Using Basal-Bolus Insulin Therapy (2IQP)

Last checked: Nov 20, 2026Latest source record: May 22, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 319 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

319

Actual

Start

Jun 1, 2023

Primary completion

Sep 24, 2024

Study completion Sep 24, 2024

Sponsor

Lead sponsor
Tandem Diabetes Care, Inc.Public (TNDM)
Sponsor type
Industry
Collaborators
Jaeb Center for Health Research
First posted
Mar 27, 2023

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

A randomized controlled trial (RCT) to assess the safety and efficacy of use of Control-IQ+ technology in adults with type 2 diabetes using basal-bolus insulin therapy.

Conditions

  • Type 2 Diabetes Treated With Insulin

Interventions

  • t:slim X2 insulin pump with Control-IQ+ technology and Dexcom G6 CGMDevice

    The t:slim X2 insulin pump with Control-IQ+ technology, used with the Dexcom G6 CGM.

  • Standard Therapy plus continuous glucose monitoring (CGM)Device

    Standard therapy is continuation of pre-study basal-bolus insulin delivery method, plus use of Dexcom G6 CGM.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. HbA1cTime frame: 13 weeks

Locations

21 sites in 2 countries. Site status is shown where the registry gives one.

  • Hoag Memorial Hospital Presbyterian

    Newport Beach, California

  • Emory University School of Medicine

    Atlanta, Georgia

  • Rocky Mountain Clinical Research

    Idaho Falls, Idaho

18 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.